BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Clinuvel 

330 Collins Street
Level 11
Melbourne  Victoria  3000  Australia
Phone: 61-3-9660-4900 Fax: 61-3-9660-4999


SEARCH JOBS










 Company News
Clinuvel Commences US Phase III Trial of SCENESSE® in Rare Light and UV Disorder 5/22/2012 12:09:46 PM    More...
Swiss Insurers Agree to Reimburse Clinuvel's SCENESSE® for Rare Disease 4/26/2012 11:41:55 AM    More...
Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide) 2/6/2012 6:14:37 AM    More...
Clinuvel Announces Positive Results From Pivotal European Phase III Study: Endpoints Demonstrate Clinically Relevant Treatment Effect of Afamelanotide 12/19/2011 3:03:58 PM    More...
Clinuvel Announces Positive Results of First Phase II US Study of SCENESSE® in Orphan Disease Erythropoietic Protoporphyria (EPP) 11/3/2011 7:33:15 AM    More...
EMA Acknowledges Clinuvel’s Novel Drug Filing in Europe in 2011 5/12/2011 9:38:35 AM    More...
Clinuvel Release: FDA Allows World First Vitiligo Drug Trial 3/2/2011 2:53:28 PM    More...
Clinuvel Completes First Phase II US Study 2/9/2011 9:10:36 AM    More...
Clinuvel Release: Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers' 7/13/2010 9:02:33 AM    More...
Clinuvel Novel UV Protecting Drug Delivered By The Picogram 7/8/2010 10:50:13 AM    More...
12